Cited by 4,233Nanoparticle-Based Drug DeliveryNanoplatforms for cancer theranosticsRadiation Therapy and Dosimetry

The DOI matches its Crossref record; 106 of the 108 references it cites were found in a registry or an index.

Nanoparticle therapeutics: an emerging treatment modality for cancer

Davis, Mark E., Chen, Zhuo, Shin, Dong M.·2008·Nature Reviews Drug Discovery

Open this paper in CoChat — free account

Abstract

Nanoparticles--particles in the size range 1-100 nm--are emerging as a class of therapeutics for cancer. Early clinical results suggest that nanoparticle therapeutics can show enhanced efficacy, while simultaneously reducing side effects, owing to properties such as more targeted localization in tumours and active cellular uptake. Here, we highlight the features of nanoparticle therapeutics that distinguish them from previous anticancer therapies, and describe how these features provide the potential for therapeutic effects that are not achievable with other modalities. While large numbers of preclinical studies have been published, the emphasis here is placed on preclinical and clinical studies that are likely to affect clinical investigations and their implications for advancing the treatment of patients with cancer.

Integrity signals

Registry

Crossref · 10.1038/nrd2614

Cites

106 of 106 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
Therapeutic Nanoparticles for Drug Delivery in Cancer
Cho, K., Wang, X., Nie, S., Chen, Z. (., & Shin, D. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1441 · Cited by 2,978
Self-citation
Mechanisms of Cancer Drug Resistance
Gottesman, M. M. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103929 · Cited by 2,643
In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags
Qian, X., Peng, X.-H., Ansari, D. O., Yin-Goen, Q., Chen, G. Z., Shin, D. M., Yang, L., Young, A. N., Wang, M. D., & Nie, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1377 · Cited by 2,201
Self-citation
Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer
Gradishar, W. J., Tjulandin, S., Davidson, N. G. P., Shaw, H., Desai, N. P., Bhar, P., Hawkins, M., & O’Shaughnessy, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.937 · Cited by 2,159
Polymer conjugates as anticancer nanomedicines
Duncan, R. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1958 · Cited by 1,956
Ligand-targeted therapeutics in anticancer therapy
Allen, T. M. (2002) · Nature reviews. Cancer · doi:10.1038/nrc903 · Cited by 1,648
Antibody Targeting of Long-Circulating Lipidic Nanoparticles Does Not Increase Tumor Localization but Does Increase Internalization in Animal Models
Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., Marks, J. D., Benz, C. C., & Park, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4199 · Cited by 1,129

Flagged first, then by citations

Show all 108 references

2 of the 108 references couldn’t be matched to a known paper.

Research works printed but not linked: 3

Kurtzberg, J., Moore, J. O. Scudiery, D. & Franklin, A. A phase II study of polyethylene glycol (PEG) conjugated L-asparaginase in patients with refractory acute leukaemias. Proc. Am. Assoc. Cancer Res. 29, 213 (1988).
Socinski, M. & Ramalingham, S. XYOTAX in NSCLC and other solid tumors. Emerging evidence on biological differences between men and women: is gender-specific therapy warranted? Chemotherapy Foundation web site [online], (2005).
Vasey, P. et al. Phase I clinical and pharmacokinetic study of PKI (HPMA copolymer doxorubicin) first member of a new class of chemotherapeutics agents: drug–polymer conjugates. Clin. Cancer Res. 5, 83–94 (1999).

Sorted by citations

Items 501–600 of 1,023

CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel
Muntimadugu, E., Kumar, R., Shantikumar, S., Rafeeqi, T. A., & Khan, W. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.03.075 · Cited by 184
Redox-Responsive Magnetic Nanoparticle for Targeted Convection-Enhanced Delivery of O 6-Benzylguanine to Brain Tumors
Stephen, Z. R., Kievit, F. M., Omid Veiseh, A., Chiarelli, P. A., Fang, C., Wang, K., Hatzinger, S. J., Ellenbogen, R. G., Silber, J. R., & Zhang, M. (2014) · ACS Nano · doi:10.1021/nn503735w · Cited by 187
Environmental mixtures of nanomaterials and chemicals: The Trojan-horse phenomenon and its relevance for ecotoxicity
Naasz, S., Altenburger, R., & Kühnel, D. (2018) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2018.04.180 · Cited by 182
Microfluidics for nano-drug delivery systems: From fundamentals to industrialization
Zhang, H., Yang, J., Sun, R., Han, S., Yang, Z., & Teng, L.-S. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.01.018 · Cited by 168
An influenza virus-inspired polymer system for the timed release of siRNA
Truong, N. P., Gu, W., Prasadam, I., Jia, Z., Crawford, R., Xiao, Y., & Monteiro, M. J. (2013) · Nature Communications · doi:10.1038/ncomms2905 · Cited by 180
In vivo assembly of nanoparticle components to improve targeted cancer imaging
Perrault, S. D., & Chan, W. C. W. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001367107 · Cited by 181
Inhalable nanoparticles, a non-invasive approach to treat lung cancer in a mouse model
Roa, W., Azarmi, S., Alhallak, K., Finlay, W. H., Magliocco, A. M., & Löbenberg, R. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.10.035 · Cited by 181
Aptamers and Their Applications in Nanomedicine
Sun, H., & Zu, Y. (2015) · Small · doi:10.1002/smll.201403073 · Cited by 181
Enzyme-responsive peptide dendrimer-gemcitabine conjugate as a controlled-release drug delivery vehicle with enhanced antitumor efficacy
Zhang, C., Pan, D., Li, J., Hu, J., Bains, A., Guys, N., Zhu, H., Li, X., Luo, K., Gong, Q., et al. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.02.047 · Cited by 181
A Supramolecular Approach for Preparation of Size‐Controlled Nanoparticles
Wang, H., Wang, S., Su, H. C., Chen, K., Armijo, A. L., Lin, W., Wang, Y., Sun, J., Kamei, K., Czernin, J. G., et al. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200900063 · Cited by 182
Applications of inorganic nanoparticles as therapeutic agents
Kim, T., & Hyeon, T. (2013) · Nanotechnology · doi:10.1088/0957-4484/25/1/012001 · Cited by 184
Surface engineering of nanoparticles for therapeutic applications
Kobayashi, K., Wei, J., Iida, R., Ijiro, K., & Niikura, K. (2014) · Polymer Journal · doi:10.1038/pj.2014.40 · Cited by 180
Conscripts of the infinite armada: systemic cancer therapy using nanomaterials
Scheinberg, D. A., Villa, C. H., Escorcia, F. E., & McDevitt, M. R. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.38 · Cited by 183
Tetraphenylethene-based highly emissive metallacage as a component of theranostic supramolecular nanoparticles
Yu, G., Cook, T. R., Li, Y., Yan, X., Wu, D., Shao, L., Shen, J., Tang, G., Huang, F., Chen, X. S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616836113 · Cited by 181
Light-sensitive lipid-based nanoparticles for drug delivery: design principles and future considerations for biological applications
Yavlovich, A., Smith, B. J., Gupta, K., Blumenthal, R. P., & Puri, A. (2010) · Molecular Membrane Biology · doi:10.3109/09687688.2010.507788 · Cited by 182
Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosis
Mishra, J., Drummond, J., Quazi, S. H., Karanki, S. S., Shaw, J., Chen, B., & Kumar, N. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2012.09.014 · Cited by 184
Synthesis and Characterization of Thermally Responsive Pluronic F127−Chitosan Nanocapsules for Controlled Release and Intracellular Delivery of Small Molecules
Zhang, W., Gilstrap, K., Wu, L., Remant Bahadur, K. C., Moss, M. A., Wang, Q., Lu, X., & He, X. (2010) · ACS Nano · doi:10.1021/nn101617n · Cited by 177
Polymeric nanomedicine for cancer MR imaging and drug delivery
Khemtong, C., Kessinger, C. W., & Gao, J. (2009) · Chemical Communications · doi:10.1039/b821865j · Cited by 186
Application of Nanotechnology in Drug Delivery
Silva, J., Fernandes, A. R., & Baptista, P. V. (2014) · InTech eBooks · doi:10.5772/58424 · Cited by 181
Development and in vitro evaluation of core–shell type lipid–polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer
Mandal, B., Mittal, N. K., Balabathula, P., Thoma, L. A., & Wood, G. C. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.10.021 · Cited by 178
Linear-dendritic drug conjugates forming long-circulating nanorods for cancer-drug delivery
Zhou, Z., Ma, X., Jin, E., Tang, J., Sui, M., Shen, Y., Kirk, E. A. V., Murdoch, W. J., & Radosz, M. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.04.012 · Cited by 180
Redox-responsive nanocapsules for intracellular protein delivery
Zhao, M., Biswas, A., Hu, B., Joo, K., Wang, P., Gu, Z., & Tang, Y. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.060 · Cited by 178
Topological insulator bismuth selenide as a theranostic platform for simultaneous cancer imaging and therapy
Li, J., Jiang, F., Yang, B., Song, X., Liu, Y., Yang, H., Cao, D., Shi, W., & Chen, G. (2013) · Scientific Reports · doi:10.1038/srep01998 · Cited by 178
Lipid-coated nanoscale coordination polymers for targeted delivery of antifolates to cancer cells
Huxford, R. C., deKrafft, K. E., Boyle, W. S., Liu, D., & Lin, W. (2011) · Chemical Science · doi:10.1039/c1sc00499a · Cited by 177
Cellular processing and destinies of artificial DNA nanostructures
Lee, D. S., Qian, H., Tay, C. Y., & Leong, D. T. (2016) · Chemical Society Reviews · doi:10.1039/c5cs00700c · Cited by 179
Nanotechnology-Based Approach in Tuberculosis Treatment
Nasiruddin, M., Neyaz, M. K., & Das, S. (2017) · Tuberculosis Research and Treatment · doi:10.1155/2017/4920209 · Cited by 177
Mass transfer in nanofluids: A review
Ashrafmansouri, S., & Esfahany, M. N. (2014) · International Journal of Thermal Sciences · doi:10.1016/j.ijthermalsci.2014.03.017 · Cited by 176
Self-assembled pH-responsive hyaluronic acid–g-poly(l-histidine) copolymer micelles for targeted intracellular delivery of doxorubicin
Qiu, L., Li, Z., Qiao, M., Long, M., Wang, M., Zhang, X., Tian, C., & Chen, D. (2013) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.12.025 · Cited by 175
Cancer stem cell therapy using doxorubicin conjugated to gold nanoparticles via hydrazone bonds
Sun, T., Wang, Y., Wang, F., Du, J., Mao, C., Sun, C., Tang, R.-Z., Liu, Y., Zhu, J., Zhu, Y., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.10.011 · Cited by 176
Physical Chemistry of Nanomedicine: Understanding the Complex Behaviors of Nanoparticles in Vivo
Lane, L. A., Qian, X., Smith, A. M., & Nie, S. (2015) · Annual Review of Physical Chemistry · doi:10.1146/annurev-physchem-040513-103718 · Cited by 178
Hybrid nanoparticles for combination therapy of cancer
He, C., Lu, J., & Lin, W. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.029 · Cited by 174
Size-Dependent Tumor Penetration and in Vivo Efficacy of Monodisperse Drug–Silica Nanoconjugates
Tang, L., Gabrielson, N. P., Uckun, F. M., Fan, T. M., & Cheng, J. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300684a · Cited by 178
Multifunctional Mesoporous Silica Nanoparticles for Combined Therapeutic, Diagnostic and Targeted Action in Cancer Treatment
Rosenholm, J. M., Sahlgren, C., & Lindén, M. (2011) · Current Drug Targets · doi:10.2174/138945011795906624 · Cited by 181
Drug delivery and controlled release from biocompatible metal–organic frameworks using mechanical amorphization
Orellana‐Tavra, C., Marshall, R. J., Baxter, E. F., Lázaro, I. A., Tao, A., Cheetham, A. K., Forgan, R. S., & Fairen‐Jiménez, D. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb02025a · Cited by 176
A Controllable Aptamer-Based Self-Assembled DNA Dendrimer for High Affinity Targeting, Bioimaging and Drug Delivery
Zhang, H., Ma, Y., Xie, Y., An, Y., Huang, Y., Zhu, Z., & Yang, C. J. (2015) · Scientific Reports · doi:10.1038/srep10099 · Cited by 174
Stimuli-Responsive Liposome Fusion Mediated by Gold Nanoparticles
Pornpattananangkul, D., Olson, S., Aryal, S., Sartor, M., Huang, C., Vecchio, K. S., & Zhang, L. (2010) · ACS Nano · doi:10.1021/nn9018587 · Cited by 173
Quaternized Silicon Nanoparticles with Polarity‐Sensitive Fluorescence for Selectively Imaging and Killing Gram‐Positive Bacteria
Zhang, X., Chen, X., Yang, J., Jia, H., Li, Y., Chen, Z., & Wu, F. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201602185 · Cited by 171
Self-citation
Nanotechnology in the diagnosis and treatment of lung cancer
Cryer, A. M., & Thorley, A. J. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.02.010 · Cited by 177
Co-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells
Sun, R., Liu, Y., Li, S.-Y., Shen, S., Du, X.-J., Xu, C.-F., Cao, Z.-T., Bao, Y., Zhu, Y.-H., Li, Y.-P., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.018 · Cited by 172
Core-crosslinked pH-sensitive degradable micelles: A promising approach to resolve the extracellular stability versus intracellular drug release dilemma
Wu, Y., Chen, W., Meng, F., Wang, Z., Cheng, R., Deng, C., Liu, H., & Zhong, Z. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.07.011 · Cited by 172
A PEGylation-Free Biomimetic Porphyrin Nanoplatform for Personalized Cancer Theranostics
Cui, L., Lin, Q., Jin, C. S., 蒋文雷, Huang, H., Ding, L., Muhanna, N., Irish, J. C., Wang, F., Chen, J., et al. (2015) · ACS Nano · doi:10.1021/acsnano.5b01077 · Cited by 175
Nanotechnology-based drug delivery for central nervous system disorders
Nguyen, T. T., Nguyen, T. T. D., Vo, T. K., An, T. N. M., Nguyen, M. K., Toi, V. V., & Vo, G. V. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112117 · Cited by 182
Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system
Kibria, G., Hatakeyama, H., & Harashima, H. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0276-2 · Cited by 172
Design and development of IT-101, a cyclodextrin-containing polymer conjugate of camptothecin
Davis, M. E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.05.005 · Cited by 171
Self-citation
Aptamer-Functionalized Nanoparticles for Medical Applications: Challenges and Opportunities
Xiao, Z., & Farokhzad, O. C. (2012) · ACS Nano · doi:10.1021/nn301869z · Cited by 171
Smart pH‐Responsive Nanocarriers Based on Nano‐Graphene Oxide for Combined Chemo‐ and Photothermal Therapy Overcoming Drug Resistance
Feng, L., Li, K., Shi, X., Gao, M., Liu, J., & Liu, Z. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201300549 · Cited by 171
Clinical Developments in Nanotechnology for Cancer Therapy
Heidel, J. D., & Davis, M. E. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0178-7 · Cited by 173
Self-citation
Magnetic Colloidal Supraparticles: Design, Fabrication and Biomedical Applications
Guo, J., Yang, W., & Wang, C. (2013) · Advanced Materials · doi:10.1002/adma.201301896 · Cited by 172
Nanotechnology for the delivery of phytochemicals in cancer therapy
Xie, J., Yang, Z., Zhou, C., Zhu, J., Lee, R. J., & Teng, L. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.04.002 · Cited by 171
Biomaterial Strategies for Immunomodulation
Hotaling, N. A., Tang, L., Irvine, D. J., & Babensee, J. E. (2015) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071813-104814 · Cited by 175
Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurements
Schluep, T., Hwang, J., Hildebrandt, I. J., Czernin, J. G., Choi, C. H. J., Alabi, C. A., Mack, B. C., & Davis, M. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905487106 · Cited by 169
Self-citation
Electrospun nanofibers for cancer diagnosis and therapy
Zhou, C., Chen, Z., Zhang, A., Hu, J., Wang, X., & Yang, Z. (2016) · Biomaterials Science · doi:10.1039/c6bm00070c · Cited by 169
Self-citation
Size, shape and surface chemistry of nano-gold dictate its cellular interactions, uptake and toxicity
Carnovale, C., Bryant, G., Shukla, R., & Bansal, V. (2016) · Progress in Materials Science · doi:10.1016/j.pmatsci.2016.04.003 · Cited by 175
Nanomanufacturing—Perspective and applications
Fang, F., Zhang, X. D., Gao, W., Guo, Y. B., Byrne, G., & Hansen, H. N. (2017) · CIRP Annals · doi:10.1016/j.cirp.2017.05.004 · Cited by 173
Development of docetaxel-loaded intravenous formulation, Nanoxel-PM™ using polymer-based delivery system
Lee, S.-W., Yun, M.-H., Jeong, S. W., In, C.-H., Kim, J.-Y., Seo, M.-H., Pai, C.-M., & Kim, S.-O. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.012 · Cited by 169
Polymeric Nanoparticle Technologies for Oral Drug Delivery
Pridgen, E. M., Alexis, F., & Farokhzad, O. C. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.06.018 · Cited by 168
Inhibition of brain tumor growth by intravenous poly(β- l -malic acid) nanobioconjugate with pH-dependent drug release
Ding, H., Inoue, S., Ljubimov, A. V., Patil, R., Portilla‐Arias, J., Hu, J., Konda, B. M., Wawrowsky, K., Fujita, M., Karabalin, N., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003919107 · Cited by 167
Making polymeric nanoparticles stimuli-responsive with dynamic covalent bonds
Jackson, A. W., & Fulton, D. A. (2012) · Polymer Chemistry · doi:10.1039/c2py20727c · Cited by 168
CRLX101 nanoparticles localize in human tumors and not in adjacent, nonneoplastic tissue after intravenous dosing
Clark, A. J., Wiley, D. T., Zuckerman, J. E., Webster, P. C., Chao, J., Lin, J. L., Yen, Y., & Davis, M. E. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603018113 · Cited by 168
Self-citation
Photonanomedicine: a convergence of photodynamic therapy and nanotechnology
Obaid, G., Broekgaarden, M., Bulin, A., Huang, H., Kuriakose, J., Liu, J., & Hasan, T. G. (2016) · Nanoscale · doi:10.1039/c5nr08691d · Cited by 170
Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice
Zhao, X., Chen, Q., Li, Y.-S., Tang, H., Liu, W., & Yang, X. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.003 · Cited by 167
Ultra-small MoS2 nanodots with rapid body clearance for photothermal cancer therapy
Liu, T., Chao, Y., Gao, M., Liang, C., Chen, Q., Song, G., Cheng, L., & Liu, Z. (2016) · Nano Research · doi:10.1007/s12274-016-1183-x · Cited by 167
Selectively Sensitizing Malignant Cells to Photothermal Therapy Using a CD44-Targeting Heat Shock Protein 72 Depletion Nanosystem
Wang, S., Tian, Y., Tian, W., Sun, J., Zhao, S., Liu, Y., Wang, C., Tang, Y., Ma, X., Teng, Z., et al. (2016) · ACS Nano · doi:10.1021/acsnano.6b03874 · Cited by 167
Magnesium Oxide (MgO) Nanoparticles: Synthetic Strategies and Biomedical Applications
Gatou, Μ.-A., Skylla, E., Dourou, P., Pippa, Ν., Gazouli, M., Lаgopati, N., & Pavlatou, E. A. (2024) · Crystals · doi:10.3390/cryst14030215 · Cited by 176
The interaction of nanoparticles with plasma proteins and the consequent influence on nanoparticles behavior
Gao, H., & He, Q. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.877442 · Cited by 170
Advanced drug and gene delivery systems based on functional biodegradable polycarbonates and copolymers
Chen, W., Meng, F., Cheng, R., Deng, C., Feijén, J., & Zhong, Z. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.023 · Cited by 167
Nanomedicines for cancer therapy: state-of-the-art and limitations to pre-clinical studies that hinder future developments
Dawidczyk, C. M., Russell, L. M., & Searson, P. C. (2014) · Frontiers in Chemistry · doi:10.3389/fchem.2014.00069 · Cited by 170
HFT-T, a Targeting Nanoparticle, Enhances Specific Delivery of Paclitaxel to Folate Receptor-Positive Tumors
Wang, X., Li, J., Wang, Y., Cho, K.-J., Gloria, K., Gjyrezi, A., Koenig, L., Giannakakou, P., Shin, H. J. C., Tighiouart, M., et al. (2009) · ACS Nano · doi:10.1021/nn900649v · Cited by 165
Self-citation
Tracking of Multimodal Therapeutic Nanocomplexes Targeting Breast Cancer in Vivo
Bardhan, R., Chen, W., Bartels, M., Pérez‐Torres, C. J., Botero, M. F., McAninch, R. W., Contreras, A., Schiff, R., Pautler, R. G., Halas, N. J., et al. (2010) · Nano Letters · doi:10.1021/nl102889y · Cited by 165
Engineered Hybrid Nanoparticles for On-Demand Diagnostics and Therapeutics
Nguyen, K. T., & Zhao, Y. (2015) · Accounts of Chemical Research · doi:10.1021/acs.accounts.5b00316 · Cited by 165
Improved Stable Indocyanine Green (ICG)‐Mediated Cancer Optotheranostics with Naturalized Hepatitis B Core Particles
Shan, W., Chen, R., Zhang, Q., Zhao, J., Chen, B., Zhou, X., Ye, S., Bi, S., Nie, L., & Ren, L. (2018) · Advanced Materials · doi:10.1002/adma.201707567 · Cited by 165
Long-acting nanoparticulate DNase-1 for effective suppression of SARS-CoV-2-mediated neutrophil activities and cytokine storm
Lee, Y. Y., Park, H. H., Park, W., Kim, H., Jang, J. G., Hong, K. S., Lee, J., Seo, H. S., Na, D. H., Kim, T. H., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120389 · Cited by 166
Nanobead-based interventions for the treatment and prevention of tuberculosis
Griffiths, G., Nyström, B., Sable, S. B., & Khuller, G. K. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2437 · Cited by 169
Chemical Components for the Design of Temperature-Responsive Vesicles as Cancer Therapeutics
Al-Ahmady, Z. S., & Kostarelos, K. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00578 · Cited by 163
Peptide Dendrimer–Doxorubicin Conjugate‐Based Nanoparticles as an Enzyme‐Responsive Drug Delivery System for Cancer Therapy
Zhang, C., Pan, D., Luo, K., She, W., Guo, C., Yang, Y., & Gu, Z. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201300601 · Cited by 163
Multifunctional HER2-Antibody Conjugated Polymeric Nanocarrier-Based Drug Delivery System for Multi-Drug-Resistant Breast Cancer Therapy
Vivek, R., Thangam, R., Babu, V. N., Rejeeth, C., Sivasubramanian, S., Gunasekaran, P., Muthuchelian, K., & Kannan, S. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am406012g · Cited by 163
Oxygen self-enriched nanoparticles functionalized with erythrocyte membranes for long circulation and enhanced phototherapy
Ren, H., Liu, J., Li, Y., Wang, H., Ge, S., Yuan, A., Hu, Y., & Wu, J. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.06.035 · Cited by 163
Recent Progress in Time‐Resolved Biosensing and Bioimaging Based on Lanthanide‐Doped Nanoparticles
Ma, Q., Wang, J., Li, Z., Lv, X., Liang, L., & Yuan, Q. (2019) · Small · doi:10.1002/smll.201804969 · Cited by 165
Applications and strategies in nanodiagnosis and nanotherapy in lung cancer
Woodman, C. B. J., Vundu, G., George, A., & Wilson, C. M. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.02.009 · Cited by 168
Ultrasound-Responsive Nanocarriers in Cancer Treatment: A Review
Awad, N. S., Paul, V., AlSawaftah, N., ter Haar, G., Allen, T. M., Pitt, W. G., & Husseini, G. A. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00212 · Cited by 168
Thermally radiative three-dimensional flow of Jeffrey nanofluid with internal heat generation and magnetic field
Shehzad, S. A., Abdullah, Z., Alsaedi, A., Abbasi, F. M., & Hayat, T. (2015) · Journal of Magnetism and Magnetic Materials · doi:10.1016/j.jmmm.2015.07.057 · Cited by 163
Tumor-Vasculature-on-a-Chip for Investigating Nanoparticle Extravasation and Tumor Accumulation
Wang, H.-F., Ran, R., Liu, Y., Hui, Y., Zeng, B., Chen, D., Weitz, D. A., & Zhao, C.-X. (2018) · ACS Nano · doi:10.1021/acsnano.8b06846 · Cited by 161
Regulating Nanomedicine – Can the FDA Handle It?
Bawa, R. (2011) · Current Drug Delivery · doi:10.2174/156720111795256156 · Cited by 162
Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities
Au, J. L. ‐., Yeung, B. Z., Wientjes, M. G., Lu, Z., & Wientjes, M. G. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.002 · Cited by 163
State-of-the-art advances of copper-based nanostructures in the enhancement of chemodynamic therapy
Hao, Y., Zhang, W., Gao, Y., Wei, Y., Shu, Y., & Wang, J. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb02360d · Cited by 164
The ROS scavenging and renal protective effects of pH-responsive nitroxide radical-containing nanoparticles
Yoshitomi, T., Hirayama, A., & Nagasaki, Y. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.014 · Cited by 160
Synergistic Cisplatin/Doxorubicin Combination Chemotherapy for Multidrug-Resistant Cancer via Polymeric Nanogels Targeting Delivery
Wu, H.-Q., Jin, H., Wang, C., Zhang, Z., Ruan, H., Sun, L., Yang, C. G., Li, Y., Qin, W., & Wang, C. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b16844 · Cited by 160
Ultrasmall mesoporous organosilica nanoparticles: Morphology modulations and redox-responsive biodegradability for tumor-specific drug delivery
Yu, L., Chen, Y., Lin, H., Du, W., Chen, H., & Shi, J. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.01.046 · Cited by 160
Single-Step Assembly of Cationic Lipid–Polymer Hybrid Nanoparticles for Systemic Delivery of siRNA
Yang, X., Dou, S., Wang, Y., Long, H., Xiong, M., Mao, C., Yao, Y., & Wang, J. (2012) · ACS Nano · doi:10.1021/nn300500u · Cited by 161
Image-guided, targeted and triggered drug delivery to tumors using polymer-based microbubbles
Fokong, S., Theek, B., Wu, Z., Koczera, P., Appold, L. C., Jorge, S., Resch‐Genger, U., van Zandvoort, M. A. M. J., Storm, G., Kiessling, F. M., et al. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.05.007 · Cited by 158
Biomimetic Nanocarrier for Direct Cytosolic Drug Delivery
Zhang, Z., Cao, W., Jin, H., Lovell, J. F., Yang, M., Ding, L., Chen, J., Corbin, I. R., Luo, Q., & Zheng, G. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200903112 · Cited by 159
Mesoporous silica nanoparticles: A multifunctional nano therapeutic system
Mai, W. X., & Meng, H. (2012) · Integrative Biology · doi:10.1039/c2ib20137b · Cited by 163
3D superhydrophobic electrospun meshes as reinforcement materials for sustained local drug delivery against colorectal cancer cells
Yohe, S. T., Herrera, V. L. M., Colson, Y. L., & Grinstaff, M. W. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.05.047 · Cited by 157
Targeted co-delivery of docetaxel, cisplatin and herceptin by vitamin E TPGS-cisplatin prodrug nanoparticles for multimodality treatment of cancer
Mi, Y., Zhao, J., & Feng, S. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.01.035 · Cited by 157
Targeted Delivery of Cisplatin to Lung Cancer Using ScFvEGFR-Heparin-Cisplatin Nanoparticles
Peng, X.-H., Wang, Y., Huang, D., Wang, Y., Shin, H. J., Chen, Z., Spewak, M. B., Mao, H. Z., Wang, X., Wang, Y., et al. (2011) · ACS Nano · doi:10.1021/nn202410f · Cited by 158
Self-citation
Engineering of Targeted Nanoparticles for Cancer Therapy Using Internalizing Aptamers Isolated by Cell-Uptake Selection
Xiao, Z., Levy‐Nissenbaum, E., Alexis, F., Lupták, A., Teply, B. A., Chan, J. M., Shi, J., Digga, E., Cheng, J. W. M., Langer, R., et al. (2012) · ACS Nano · doi:10.1021/nn204165v · Cited by 157
Design of nanocarriers based on complex biological barriers in vivo for tumor therapy
Liu, J., Li, M., Luo, Z. Y., Dai, L., Guo, X., & Cai, K. (2017) · Nano Today · doi:10.1016/j.nantod.2017.06.010 · Cited by 158
Peptide modified gold nanoparticles for improved cellular uptake, nuclear transport, and intracellular retention
Yang, C., Uertz, J., Yohan, D., & Chithrani, B. D. (2014) · Nanoscale · doi:10.1039/c4nr02535k · Cited by 156
Paclitaxel-loaded poly(N-vinylpyrrolidone)-b-poly(ε-caprolactone) nanoparticles: Preparation and antitumor activity in vivo
Zhu, Z., Li, Y., Li, X., Li, R., Jia, Z., Li, R., Guo, W., Wu, W., & Jiang, X. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.11.002 · Cited by 156
Recent Advances in Nanomicelles Delivery Systems.
Tawfik, S. M., Azizov, S., Elmasry, M. R., Sharipov, M., & Lee, Y.-I. (2020) · Nanomaterials · doi:10.3390/nano11010070 · Cited by 156

Authors: Davis, M. E., Chen, Z., & Shin, D. M.
Affiliations: California Institute of Technology (US)
Emory University (US)
Corresponding author: Davis, Mark E.
ORCID: Davis, Mark E.
Chen, Zhuo
Shin, Dong M.
Venue: Nature Reviews Drug Discovery
Publisher: Springer Science and Business Media LLC
Published: 2008-09
Volume: 7
Issue: 9
Pages: 771-782
ISSN: 1474-1776 (ISSN-L)
1474-1784
DOI: 10.1038/nrd2614
OpenAlex: W2082511916
Cited by: 4,233
References: 108
Citations by year: 2026: 68 · 2025: 134 · 2024: 165 · 2023: 143 · 2022: 171 · 2021: 217 · 2020: 224 · 2019: 260 · 2018: 316 · 2017: 340 · 2016: 364 · 2015: 383 · 2014: 385 · 2013: 332 · 2012: 268
FWCI: 7.10
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature Reviews Drug Discovery (publishedVersion)
PubMed (publishedVersion)
CaltechAUTHORS (California Institute of Technology) (submittedVersion)
Funders: National Cancer Institute (U54CA119338)
Topics: Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
Keywords: nanotherapeutics, cancer therapy, nanomedicine, targeted drug delivery, tumor localization, cellular uptake, clinical translation, clinical trials, anticancer agents, adverse drug reactions
MeSH terms: Animals, Antineoplastic Agents, Clinical Trials as Topic, Drug Evaluation, Preclinical, Humans, Neoplasms, Drug Delivery Systems, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Nanoparticle therapeutics: an emerging treatment modality for cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks